According to AcelRx Pharmaceuticals 's latest financial reports the company's total debt is โฌ2.9 Million. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2022-12-31 | โฌ9.71 M | -40.9% |
2021-12-31 | โฌ16.44 M | -21% |
2020-12-31 | โฌ20.81 M | -21.65% |
2019-12-31 | โฌ26.56 M | 153.43% |
2018-12-31 | โฌ10.48 M | -34.14% |
2017-12-31 | โฌ15.91 M | -22.31% |
2016-12-31 | โฌ20.48 M | 7.07% |
2015-12-31 | โฌ19.13 M | -6.56% |
2014-12-31 | โฌ20.47 M | 96.88% |
2013-12-31 | โฌ10.4 M | -13.87% |
2012-12-31 | โฌ12.07 M | -17.81% |
2011-12-31 | โฌ14.69 M | 62.72% |
2010-12-31 | โฌ9.02 M | 32.89% |
2009-12-31 | โฌ6.79 M | -22.99% |
2008-12-31 | โฌ8.82 M |
Company | Total debt/th> | differencediff. | Country |
---|---|---|---|
![]() Cara Therapeutics
CARA | N/A | N/A | ๐บ๐ธ USA |
![]() Recro Pharma
REPH | N/A | N/A | ๐บ๐ธ USA |